Logo.jpg
Plant Biotechnology Market To Reach USD 276.9 Billion By 2032 - DataHorizzon Research
06 avr. 2024 10h00 HE | DataHorizzon Research
Fort Collins, Colorado, April 06, 2024 (GLOBE NEWSWIRE) -- The Plant Biotechnology Market was valued at USD 105.1 Billion in 2023 and is anticipated to grow CAGR at 11.4% and reach USD 276.9 Billion...
Global Market for Plant Biotechnology Equipment
Key Players and Market Dynamics Explored in Latest Plant Biotechnology Equipment Report
30 août 2023 07h48 HE | Research and Markets
Dublin, Aug. 30, 2023 (GLOBE NEWSWIRE) -- The "Plant Biotechnology Equipment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The "Global Strategic...
22nd Century Group logo.jpg
22nd Century Group Reports Business Highlights and Financial Results for the Second Quarter 2021
05 août 2021 06h00 HE | 22nd Century Group, Inc
Initiated International Launch Process For VLN®, First Sales Planned by First Quarter 2022First Revenue From Hemp/Cannabis Franchise to Commence in Second Half of 2021Third Plant-Based Franchise to be...
22nd Century Group logo.jpg
22nd Century Advances Initiatives to Strengthen and Maximize Revenue Opportunities in Hemp/Cannabis Franchise
07 juin 2021 10h42 HE | 22nd Century Group, Inc
Close Partnership With Aurora Cannabis Inc. to Enforce Shared Global Biosynthesis IP Rights Against Infringement and Actively Explore Commercial Development Opportunities; Monetization of Key Patented...
22nd Century Group logo.jpg
22nd Century Announces $40 Million Common Stock Registered Direct Offering
07 juin 2021 09h25 HE | 22nd Century Group, Inc
BUFFALO, N.Y., June 07, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine...
22nd Century Group logo.jpg
22nd Century Group Receives Additional $3.7 Million from Cash Exercise of Outstanding Warrants
12 mars 2021 10h00 HE | 22nd Century Group, Inc
WILLIAMSVILLE, N.Y., March 12, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low...
22nd Century Group logo.jpg
22nd Century Group Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2020
11 mars 2021 07h00 HE | 22nd Century Group, Inc
Key Business and Financial Highlights 22nd Century has a tremendous global commercial opportunity in the more than $800 billion markets across the tobacco and hemp/cannabis industry.Securing Modified...
22nd Century Group logo.jpg
22nd Century Group Receives $8.1 Million from Cash Exercise of Outstanding Warrants
04 mars 2021 09h15 HE | 22nd Century Group, Inc
WILLIAMSVILLE, N.Y., March 04, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low...